Health Care / Hospitals
Releases published in the last 30 days. 
Page 1 of 3
- Ultomiris granted Priority Review in the US as treatment for adults with immunoglobulin A nephropathy
- 6/15/2026 10:48:37 AM
- Based on I CAN Phase III trial results from prespecified interim analysis in which Ultomiris demonstrated 43.4% reduction in proteinuria vs placebo at 34 weeks If approved, Ultomiris would be the first C5 complement inhibitor available for this rare kidney disease Alexion, AstraZeneca Rare Disease’s supplemental Biologics License Application (sBLA) for …
- Caring for non-communicable diseases during pregnancy, expert convening
- 6/15/2026 10:36:28 AM
- The World Health Organization (WHO) is developing new recommendations to improve care for pregnant and postpartum women living with noncommunicable diseases (NCDs).
- “Beyond Feet on Fire” is Free to Download for Only Five Days (Until 6/19/26)
- 6/15/2026 6:00:00 AM
- Best Seller Publishing announces the release of Dr. Paul Fisher’s new book, “Beyond Feet on Fire: How To Reverse Neuropathy Without Drugs and Surgery.” It will be available in the Amazon store for free for only five days.
- Bombardier Defense Expands Collaboration with Aero-Dienst/ADAC with a Second Challenger 650 Aircraft for Medevac
- 6/12/2026 10:48:35 AM
- • Bombardier Defense signs deal with German-based operator Aero-Dienst GmbH, a wholly owned subsidiary of ADAC SE, for a second Bombardier Challenger 650 aircraft that will be added to its medevac fleet • The Challenger 650 aircraft supports critical missions worldwide with proven reliability, long-range performance and cabin flexibility • Additional aircraft …
- Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients
- 6/12/2026 10:38:47 AM
- • Expanded U.S. availability paired with new patient lifestyle quiz encourages informed decision-making ahead of cataract surgery. • Cataracts are one of the leading causes of vision impairment.1 Nearly 20% of Americans aged 40+ live with cataracts that make everyday tasks more challenging, yet only 5% have had cataract surgery.2 • Over half a million eyes worldwide …
- Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy
- 6/10/2026 6:17:01 PM
- Sanofi today announced that the riliprubart MOBILIZE phase 3 study (clinical study identifier: NCT06290128) in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) refractory to standard-of-care treatment will be stopped.
- Huawei Launches the "AHEAD" Program to Build a New Ecosystem for Mutual Benefits in Education and Healthcare
- 6/10/2026 6:10:47 PM
- The 2026 Global Education & Healthcare Partners Convention, convened under the theme “Together, Enabling Intelligent-led Education & Healthcare,” successfully concluded in China.
- Message by the Director of the Department of Immunization, Vaccines and Biologicals at WHO - May 2026
- 6/10/2026 9:20:39 AM
- At the mid-way point of Immunization Agenda 2030 (IA2030), countries gathering at the Seventy-ninth World Health Assembly (WHA79) marked an important moment in reaffirming their commitment to reaching everyone, everywhere with life-saving vaccines.
- AMA adopts new policies to improve affordable access to obesity treatments
- 6/9/2026 9:02:36 AM
- Physicians and medical students convened for the Annual Meeting of the American Medical Association’s (AMA) House of Delegates today and adopted new policies aimed at improving patient access to evidence-based obesity treatments while advancing broader efforts to address prescription drug affordability and insurance coverage barriers.
- Wiley Launches Advanced Brain to Push Disciplinary Boundaries Across Neuroscience & Related Fields
- 6/9/2026 8:08:00 AM
- Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced the launch of Advanced Brain, an open access, interdisciplinary journal dedicated to publishing cutting-edge research across neuroscience, neurology, psychiatry and psychology.
- Mental health: although screens can play a negative role, more than 6 out of 10 people turn to artificial intelligence for psychological support
- 6/8/2026 5:23:06 PM
- • AXA and Ipsos have surveyed people in 18 countries about their mental health, which continues to decline. 46% of those surveyed say they are struggling or languishing.
- Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector
- 6/8/2026 10:37:39 AM
- Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector • Sarclisa administered via the CirCLIQ ® OBI offers a treatment experience designed around the needs of patients and HCPs and enables flexible administration in either home or outpatient settings • Sarclisa is the first anticancer treatment to …
- Thrifty Food Plan Costs Vary Widely Across US Regions and Cities
- 6/8/2026 9:58:55 AM
- A recent study in the Journal of Nutrition Education and Behavior (JNEB), published by Elsevier, examined how the cost of the USDA’s Thrifty Food Plan (TFP), which serves as the basis for determining maximum SNAP benefits, varied across geographic regions, metropolitan areas, and seasons from 2012 to 2018.
- Can taking aspirin uncover asymptomatic bladder cancer?
- 6/5/2026 9:21:01 AM
- The presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood clots, the medication can cause mild bleeding or worsen existing bleeding in the urinary tract.
- Increased transport costs mean less money for the lifesaving supplies children need
- 6/4/2026 10:20:00 AM
- “Nearly 100 days into the latest Middle East escalation, the fallout extends far beyond the region. The disruption to global humanitarian supply chains is impacting children across the globe, with continued congestion in global supply routes, and higher transport costs at all levels.
- Rick Hansen Foundation, RBC and RBC Foundation Announce 40 Recipients of the RBC Barrier Buster Grants Program
- 6/3/2026 10:18:29 AM
- • Forty communities across Canada -- including municipalities, schools and community groups -- will each receive grants of up to $40,000 to fund physical accessibility improvements through RBC Barrier Buster Grants Program.
- Kaiser Permanente names Emily Holliman president of Mid-Atlantic States region
- 6/3/2026 10:07:22 AM
- Kaiser Permanente has appointed Emily Holliman as president of Kaiser Permanente in the Mid-Atlantic States, effective immediately. Holliman has served as the region’s interim president since June 2025, leading efforts to provide high-quality, integrated health care and coverage to the organization’s 750,551 members across 35 medical centers in Maryland, Virginia, and …
- Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study
- 6/3/2026 10:03:16 AM
- · Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and reduce pathogenic immunoglobulin G (IgG) autoantibodies associated with this disease while preserving immune function · Results demonstrated significant reduction of systemic lupus erythematosus disease activity which continued …
- “9 Simple Solutions to Achieve Health Equity” Will Be Available as a FREE Download for Five Days on Amazon (ending 06/05/2026)
- 6/3/2026 6:00:00 AM
- Best Seller Publishing is pleased to announce a limited-time FREE eBook for “9 Simple Solutions to Achieve Health Equity: A Guide for Healthcare Professionals and Patients” by Mauvareen Beverley, M.D., a nationally recognized expert in patient engagement and health equity.
- FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
- 6/2/2026 10:54:17 AM
- The U.S. Food and Drug Administration (FDA) today issued draft guidance to help developers bring promising gene therapies to patients more efficiently by making greater use of existing scientific and regulatory knowledge.